Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H8N4O3 |
| Molecular Weight | 196.1634 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C2=C(NC(=O)N2)C(=O)N(C)C1=O
InChI
InChIKey=OTSBKHHWSQYEHK-UHFFFAOYSA-N
InChI=1S/C7H8N4O3/c1-10-4-3(8-6(13)9-4)5(12)11(2)7(10)14/h1-2H3,(H2,8,9,13)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Use of novel solid-phase extraction sorbent materials for high-performance liquid chromatography quantitation of caffeine metabolism products methylxanthines and methyluric acids in samples of biological origin. | 2001 Aug 15 |
|
| Caffeine metabolism in a group of 67 patients with primary biliary cirrhosis. | 2001 Jan |
|
| Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats. | 2003 Jan 31 |
|
| Methylated purines in urinary stones. | 2005 Aug |
|
| Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m). | 2005 Mar |
|
| Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation. | 2005 Sep |
|
| Associations between CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluric acid/theophylline ratios. | 2006 Aug |
|
| Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine. | 2006 May |
|
| Time-dependent effects of Klebsiella pneumoniae endotoxin (KPLPS) on the pharmacokinetics of theophylline in rats: return of the parameters in 96-hour KPLPS rats to the control levels. | 2008 May |
|
| Relaxing and contracting effects of theophylline's metabolites on the rabbit upper gastrointestinal tract. | 2008 Oct |
|
| Nitrosation of N-methyl derivatives of uric acid and their transnitrosation ability to N-acetylcysteine. | 2010 Sep |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID50241466
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
213-410-1
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
68447
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
95854
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
C031274
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
70346
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
944-73-0
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY | |||
|
C222JTI9I3
Created by
admin on Fri Dec 15 18:36:15 GMT 2023 , Edited by admin on Fri Dec 15 18:36:15 GMT 2023
|
PRIMARY |
PARENT (METABOLITE INACTIVE)
SUBSTANCE RECORD
